Abstract | BACKGROUND: RESULTS: We show that CEACAM1 is expressed in a tissue specific manner with significant differences in the ratios of its short (CEACAM1-S) and long (CEACAM1-L) cytoplasmic domain splice variants. Importantly, we find dramatic differences between the ratios of S:L isoforms in normal breast tissues versus breast cancer specimens, suggesting that altered splicing of CEACAM1 may play an important role in tumorogenesis. Furthermore, we have identified two regulatory cis-acting elements required for the alternative splicing of CEACAM1. Replacement of these regulatory elements by human beta-globin exon sequences resulted in exon 7-skipped mRNA as the predominant product. Interestingly, while insertion of exon 7 in a beta-globin reporter gene resulted in its skipping, exon 7 along with the flanking intron sequences recapitulated the alternative splicing of CEACAM1. CONCLUSION: Our results indicate that a network of regulatory elements control the alternative splicing of CEACAM1. These findings may have important implications in therapeutic modalities of CEACAM1 linked human diseases.
|
Authors | Shikha Gaur, John E Shively, Yun Yen, Rajesh K Gaur |
Journal | Molecular cancer
(Mol Cancer)
Vol. 7
Pg. 46
(May 28 2008)
ISSN: 1476-4598 [Electronic] England |
PMID | 18507857
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Antigens, CD
- CD66 antigens
- Cell Adhesion Molecules
- Protein Isoforms
|
Topics |
- Alternative Splicing
(genetics)
- Antigens, CD
(genetics, metabolism)
- Breast Neoplasms
(genetics, metabolism)
- Cell Adhesion Molecules
(genetics, metabolism)
- Cell Line, Tumor
- Cytoplasm
(metabolism)
- Exons
(genetics)
- Gene Expression Regulation, Neoplastic
- Health
- Humans
- Introns
(genetics)
- Protein Isoforms
(genetics, metabolism)
- Regulatory Sequences, Nucleic Acid
|